## Abstract In major depression, one line of research indicates that a dysfunctional GABAergic inhibitory system is linked to the appearance of depressive symptoms. However, as the mechanistic details of such GABAergic deficit are largely unknown, we undertook a functional investigation of the GABA
Effects of the novel antidepressant milnacipran in a chronic mild stress model of depression
✍ Scribed by Mariusz Papp; Emmanuel Panconi; Piotr Gruca
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 85 KB
- Volume
- 61
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract One hypothesis of depression is that it is caused by reduced neuronal plasticity including hippocampal neurogenesis. In this study, we compared the effects of three long‐term antidepressant treatments: escitalopram, voluntary running, and their combination on hippocampal cell proliferat
## Abstract Escitalopram (ES‐CIT) is a widely used, highly specific antidepressant. Until now there has been very little evidence on how this drug under pathological conditions affects an important feature within the pathophysiology of stress‐related disorders such as depression: the endogenous neu
## Abstract In this study, we attempt to examine the feasibility of the bioactive tissue‐engineered sling by using muscle precursor cells (MPCs)‐seeded Poly(ε‐caprolactone) (PCL) nanofiber sheet in a rat model of stress urinary incontinence (SUI). __In vitro__, MPCs were cultured on a PCL nanofiber
Two single doses (300 and 600 mg) of fengabine, a novel antidepressant, a single dose (50 mg) of amitriptyline, and a single dose of placebo were taken by sixteen male healthy volunteers (18-30 years), in weekly experimental sessions, according to a balanced double-blind cross-over design. In Part A